Expression of YTHDF3 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

YTHDF3 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 16.48

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

19.8

Number of samples

141

Samples

Sample	Description	TPM
TCGA-28-5218-01A	0 years, male, white, stage:'--, dead, 157 days	41.1
TCGA-06-2569-01A	0 years, female, black or african american, stage:'--, alive, 13 days	37.6
TCGA-28-5215-01A	0 years, female, white, stage:'--, dead, 335 days	34.3
TCGA-06-2565-01A	0 years, male, asian, stage:'--, dead, 506 days	31.1
TCGA-06-5417-01A	0 years, female, white, stage:'--, alive, 155 days	30.0
TCGA-06-2559-01A	0 years, male, white, stage:'--, dead, 150 days	28.8
TCGA-06-2564-01A	0 years, male, white, stage:'--, alive, 181 days	27.9
TCGA-28-5209-01A	0 years, female, white, stage:'--, alive, 442 days	27.9
TCGA-14-1825-01A	0 years, male, white, stage:'--, dead, 232 days	27.6
TCGA-06-0129-01A	0 years, male, asian, stage:'--, dead, 1024 days	27.4
TCGA-12-0821-01A	0 years, male, white, stage:'--, dead, 323 days	27.3
TCGA-32-2634-01A	0 years, male, white, stage:'--, alive, 693 days	26.8
TCGA-06-2558-01A	0 years, female, white, stage:'--, dead, 380 days	26.6
TCGA-06-0878-01A	0 years, male, white, stage:'--, alive, 218 days	26.2
TCGA-06-1804-01A	0 years, female, white, stage:'--, dead, 414 days	26.2
TCGA-02-0055-01A	0 years, female, white, stage:'--, dead, 76 days	26.2
TCGA-06-0174-01A	0 years, male, white, stage:'--, dead, 98 days	25.9
TCGA-28-5204-01A	0 years, male, white, stage:'--, dead, 454 days	25.7
TCGA-28-5208-01A	0 years, male, white, stage:'--, dead, 544 days	25.6
TCGA-06-0211-01A	0 years, male, white, stage:'--, dead, 360 days	25.6
TCGA-06-0125-01A	0 years, female, white, stage:'--, dead, 1448 days	25.5
TCGA-08-0386-01A	0 years, male, white, stage:'--, dead, 548 days	25.0
TCGA-02-2483-01A	0 years, male, asian, stage:'--, alive, 466 days	25.0
TCGA-19-1390-01A	0 years, female, white, stage:'--, dead, 772 days	24.9
TCGA-19-5960-01A	0 years, male, white, stage:'--, dead, 455 days	24.9
TCGA-15-1444-01A	0 years, male, white, stage:'--, dead, 1537 days	24.6
TCGA-12-3653-01A	0 years, female, white, stage:'--, dead, 442 days	24.6
TCGA-06-5858-01A	0 years, female, white, stage:'--, alive, 187 days	24.6
TCGA-06-2562-01A	0 years, male, white, stage:'--, dead, 382 days	24.3
TCGA-06-2567-01A	0 years, male, white, stage:'--, dead, 133 days	23.9
TCGA-32-2638-01A	0 years, male, white, stage:'--, dead, 766 days	23.8
TCGA-27-1834-01A	0 years, male, white, stage:'--, dead, 1233 days	23.6
TCGA-06-0156-01A	0 years, male, white, stage:'--, dead, 178 days	23.5
TCGA-14-1829-01A	0 years, male, black or african american, stage:'--, alive, 218 days	23.3
TCGA-41-4097-01A	0 years, female, white, stage:'--, dead, 6 days	23.2
TCGA-14-2554-01A	0 years, female, white, stage:'--, dead, 532 days	23.1
TCGA-06-5418-01A	0 years, female, white, stage:'--, dead, 83 days	23.1
TCGA-06-2563-01A	0 years, female, white, stage:'--, alive, 932 days	23.1
TCGA-27-2528-01A	0 years, male, white, stage:'--, dead, 480 days	22.9
TCGA-26-5139-01A	0 years, female, white, stage:'--, alive, 48 days	22.9
TCGA-27-1830-01A	0 years, male, white, stage:'--, dead, 154 days	22.7
TCGA-06-0210-01A	0 years, female, white, stage:'--, dead, 225 days	22.6
TCGA-06-5414-01A	0 years, male, white, stage:'--, alive, 273 days	22.5
TCGA-12-0618-01A	0 years, male, white, stage:'--, dead, 395 days	22.4
TCGA-06-5856-01A	0 years, male, white, stage:'--, dead, 114 days	22.2
TCGA-06-5859-01A	0 years, male, white, stage:'--, alive, 139 days	22.1
TCGA-27-2523-01A	0 years, male, white, stage:'--, dead, 489 days	22.1
TCGA-14-0789-01A	0 years, male, white, stage:'--, dead, 342 days	22.0
TCGA-06-5413-01A	0 years, male, white, stage:'--, alive, 268 days	21.9
TCGA-06-0190-01A	0 years, male, white, stage:'--, dead, 317 days	21.7
TCGA-28-2514-01A	0 years, male, asian, stage:'--, alive, 160 days	21.6
TCGA-76-4925-01A	0 years, male, white, stage:'--, dead, 146 days	21.6
TCGA-27-1831-01A	0 years, male, white, stage:'--, dead, 505 days	21.4
TCGA-06-0882-01A	0 years, male, white, stage:'--, dead, 632 days	21.2
TCGA-06-0158-01A	0 years, male, white, stage:'--, dead, 329 days	21.2
TCGA-06-0130-01A	0 years, male, white, stage:'--, dead, 394 days	21.2
TCGA-12-5299-01A	0 years, female, white, stage:'--, dead, 98 days	21.0
TCGA-76-4931-01A	0 years, female, white, stage:'--, dead, 279 days	20.9
TCGA-19-4065-01A	0 years, male, white, stage:'--, alive, 214 days	20.9
TCGA-06-2561-01A	0 years, female, white, stage:'--, dead, 537 days	20.8
TCGA-28-5207-01A	0 years, male, white, stage:'--, dead, 343 days	20.8
TCGA-06-0157-01A	0 years, female, white, stage:'--, dead, 97 days	20.8
TCGA-26-5133-01A	0 years, male, white, stage:'--, alive, 452 days	20.6
TCGA-06-2557-01A	0 years, male, black or african american, stage:'--, dead, 33 days	20.5
TCGA-19-2619-01A	0 years, female, black or african american, stage:'--, alive, 294 days	19.9
TCGA-06-0644-01A	0 years, male, black or african american, stage:'--, dead, 384 days	19.8
TCGA-32-1970-01A	0 years, male, white, stage:'--, dead, 468 days	19.7
TCGA-06-0646-01A	0 years, male, white, stage:'--, dead, 175 days	19.7
TCGA-32-2616-01A	0 years, female, white, stage:'--, dead, 224 days	19.6
TCGA-02-0047-01A	0 years, male, white, stage:'--, dead, 448 days	19.6
TCGA-06-0187-01A	0 years, male, white, stage:'--, dead, 828 days	19.5
TCGA-06-2570-01A	0 years, female, white, stage:'--, alive, 958 days	19.3
TCGA-14-1034-01A	0 years, female, stage:'--, dead, 485 days	19.3
TCGA-28-1753-01A	0 years, male, white, stage:'--, alive, 37 days	19.3
TCGA-06-0132-01A	0 years, male, white, stage:'--, dead, 771 days	18.9
TCGA-14-0871-01A	0 years, female, white, stage:'--, dead, 880 days	18.8
TCGA-06-5408-01A	0 years, female, white, stage:'--, dead, 357 days	18.8
TCGA-76-4927-01A	0 years, male, white, stage:'--, dead, 535 days	18.8
TCGA-02-2485-01A	0 years, male, black or african american, stage:'--, alive, 470 days	18.7
TCGA-41-5651-01A	0 years, female, black or african american, stage:'--, dead, 460 days	18.7
TCGA-12-3650-01A	0 years, male, white, stage:'--, dead, 333 days	18.5
TCGA-41-2572-01A	0 years, male, white, stage:'--, dead, 406 days	18.5
TCGA-76-4932-01A	0 years, female, white, stage:'--, dead, 1458 days	18.4
TCGA-27-2526-01A	0 years, female, white, stage:'--, dead, 87 days	18.3
TCGA-06-0747-01A	0 years, male, white, stage:'--, dead, 82 days	18.0
TCGA-27-2519-01A	0 years, male, white, stage:'--, dead, 550 days	18.0
TCGA-32-2615-01A	0 years, male, white, stage:'--, dead, 485 days	17.9
TCGA-28-2513-01A	0 years, female, white, stage:'--, alive, 222 days	17.6
TCGA-12-0619-01A	0 years, male, white, stage:'--, dead, 1062 days	17.4
TCGA-32-2632-01A	0 years, male, white, stage:'--, dead, 269 days	17.4
TCGA-32-5222-01A	0 years, male, white, stage:'--, dead, 585 days	17.3
TCGA-12-3652-01A	0 years, male, white, stage:'--, dead, 1062 days	17.2
TCGA-41-3915-01A	0 years, male, white, stage:'--, dead, 360 days	17.0
TCGA-06-0139-01A	0 years, male, white, stage:'--, dead, 362 days	17.0
TCGA-76-4929-01A	0 years, female, white, stage:'--, dead, 111 days	16.8
TCGA-26-5132-01A	0 years, male, white, stage:'--, alive, 286 days	16.8
TCGA-28-5220-01A	0 years, male, white, stage:'--, dead, 388 days	16.8
TCGA-19-2629-01A	0 years, male, white, stage:'--, dead, 737 days	16.6
TCGA-06-5416-01A	0 years, female, white, stage:'--, alive, 204 days	16.5
TCGA-06-0184-01A	0 years, male, white, stage:'--, dead, 2126 days	16.5
TCGA-19-2624-01A	0 years, male, white, stage:'--, dead, 5 days	16.5
TCGA-32-1982-01A	0 years, female, white, stage:'--, dead, 142 days	16.4
TCGA-28-2509-01A	0 years, female, white, stage:'--, alive, 145 days	16.3
TCGA-14-1823-01A	0 years, female, white, stage:'--, dead, 543 days	16.3
TCGA-06-0168-01A	0 years, female, white, stage:'--, dead, 598 days	16.3
TCGA-06-0238-01A	0 years, male, white, stage:'--, dead, 405 days	16.2
TCGA-14-0787-01A	0 years, male, asian, stage:'--, dead, 68 days	16.2
TCGA-27-1837-01A	0 years, male, white, stage:'--, dead, 427 days	16.1
TCGA-06-5412-01A	0 years, female, white, stage:'--, dead, 138 days	16.1
TCGA-27-2521-01A	0 years, male, white, stage:'--, dead, 510 days	16.1
TCGA-06-0645-01A	0 years, female, white, stage:'--, dead, 175 days	16.1
TCGA-12-0616-01A	0 years, female, white, stage:'--, dead, 448 days	16.1
TCGA-06-5411-01A	0 years, male, white, stage:'--, dead, 254 days	15.9
TCGA-12-5295-01A	0 years, female, white, stage:'--, dead, 454 days	15.4
TCGA-06-0686-01A	0 years, male, white, stage:'--, dead, 432 days	15.3
TCGA-06-5410-01A	0 years, female, white, stage:'--, dead, 108 days	15.3
TCGA-14-0817-01A	0 years, female, white, stage:'--, dead, 164 days	15.2
TCGA-28-5216-01A	0 years, male, white, stage:'--, alive, 415 days	15.1
TCGA-06-0138-01A	0 years, male, white, stage:'--, dead, 737 days	15.1
TCGA-27-1832-01A	0 years, female, white, stage:'--, dead, 300 days	15.0
TCGA-06-0141-01A	0 years, male, white, stage:'--, dead, 313 days	14.9
TCGA-27-1835-01A	0 years, female, white, stage:'--, dead, 648 days	14.2
TCGA-19-2620-01A	0 years, male, white, stage:'--, dead, 148 days	14.0
TCGA-26-5135-01A	0 years, female, white, stage:'--, dead, 270 days	13.5
TCGA-32-1980-01A	0 years, male, white, stage:'--, dead, 36 days	13.4
TCGA-06-0219-01A	0 years, male, white, stage:'--, dead, 22 days	13.3
TCGA-26-1442-01A	0 years, male, white, stage:'--, alive, 953 days	12.9
TCGA-15-0742-01A	0 years, male, white, stage:'--, dead, 419 days	12.9
TCGA-06-0745-01A	0 years, male, white, stage:'--, dead, 239 days	12.7
TCGA-32-4213-01A	0 years, female, white, stage:'--, alive, 604 days	12.4
TCGA-41-2571-01A	0 years, male, white, stage:'--, dead, 26 days	11.9
TCGA-16-0846-01A	0 years, male, white, stage:'--, dead, 119 days	11.7
TCGA-06-0744-01A	0 years, male, white, stage:'--, dead, 1426 days	11.6
TCGA-06-0750-01A	0 years, male, white, stage:'--, dead, 28 days	11.6
TCGA-19-2625-01A	0 years, female, white, stage:'--, dead, 124 days	11.6
TCGA-06-0743-01A	0 years, male, white, stage:'--, dead, 803 days	11.3
TCGA-06-0178-01A	0 years, male, white, stage:'--, dead, 2681 days	10.4
TCGA-06-0749-01A	0 years, male, black or african american, stage:'--, dead, 82 days	9.8
TCGA-02-2486-01A	0 years, male, white, stage:'--, dead, 618 days	9.5
TCGA-27-2524-01A	0 years, male, white, stage:'--, dead, 231 days	9.0
TCGA-26-5134-01A	0 years, male, white, stage:'--, alive, 167 days	7.3
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

YTHDF3 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 21.55

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

20.0

Number of samples

Samples

Sample	Description	TPM
AK123	N, NA, stage:NA, dead, 180 days	27.9
AK081	N, NA, stage:NA, dead, 180 days	26.9
AK117	N, NA, stage:NA, dead, 210 days	26.5
AK156	N, NA, stage:NA, dead, 330 days	26.4
AK124	N, NA, stage:NA, alive, 1920 days	26.3
AK066	N, NA, stage:NA, alive, 960 days	25.8
AK099	N, NA, stage:NA, dead, 420 days	25.3
AK003	N, NA, stage:NA, dead, 600 days	24.3
AK089	N, NA, stage:NA, dead, 330 days	24.1
AK153	N, NA, stage:NA, dead, 240 days	23.5
AK226	N, NA, stage:NA, dead, 360 days	22.8
AK218	N, NA, stage:NA, dead, 180 days	22.5
AK149	N, NA, stage:NA, dead, 420 days	22.3
AK041	N, NA, stage:NA, alive, 810 days	22.0
AK205	N, NA, stage:NA, dead, 120 days	21.9
AK005	N, NA, stage:NA, dead, 240 days	21.8
AK100	N, NA, stage:NA, alive, 960 days	21.3
AK006	N, NA, stage:NA, dead, 360 days	21.2
AK035	N, NA, stage:NA, dead, 210 days	21.2
AK051	N, NA, stage:NA, dead, 360 days	21.0
AK085	N, NA, stage:NA, alive, 660 days	20.9
AK165	N, NA, stage:NA, alive, 360 days	20.7
AK002	N, NA, stage:NA, dead, 570 days	20.6
AK236	N, NA, stage:NA, dead, 360 days	20.5
AK216	N, NA, stage:NA, dead, 360 days	20.4
AK158	N, NA, stage:NA, dead, 360 days	20.3
AK074	N, NA, stage:NA, alive, 300 days	20.1
AK188	N, NA, stage:NA, alive, 420 days	20.0
AK183	N, NA, stage:NA, alive, 360 days	20.0
AK068	N, NA, stage:NA, alive, 360 days	19.9
AK227	N, NA, stage:NA, alive, 300 days	19.7
AK071	N, NA, stage:NA, dead, 540 days	19.6
AK173	N, NA, stage:NA, dead, 180 days	19.5
AK049	N, NA, stage:NA, dead, 180 days	19.4
AK030	N, NA, stage:NA, dead, 120 days	19.3
AK079	N, NA, stage:NA, dead, 210 days	19.0
AK103	N, NA, stage:NA, alive, 1320 days	18.7
AK102	N, NA, stage:NA, alive, 1740 days	18.6
AK091	N, NA, stage:NA, dead, 210 days	18.2
AK167	N, NA, stage:NA, dead, 180 days	18.0
AK098	N, NA, stage:NA, dead, 660 days	18.0
AK195	N, NA, stage:NA, dead, 390 days	17.9
AK139	N, NA, stage:NA, dead, 270 days	17.9
AK053	N, NA, stage:NA, dead, 300 days	17.8
AK088	N, NA, stage:NA, dead, 360 days	17.7
AK142	N, NA, stage:NA, alive, 90 days	17.5
AK134	N, NA, stage:NA, dead, 360 days	17.1
AK043	N, NA, stage:NA, alive, 660 days	16.9
AK178	N, NA, stage:NA, dead, 240 days	16.6
AK015	N, NA, stage:NA, alive, 720 days	16.5
AK072	N, NA, stage:NA, dead, 150 days	16.2
AK213	N, NA, stage:NA, alive, 2010 days	15.9
AK199	N, NA, stage:NA, alive, 1860 days	15.5
AK076	N, NA, stage:NA, alive, 660 days	15.5
AK133	N, NA, stage:NA, dead, 360 days	15.1
AK055	N, NA, stage:NA, dead, 240 days	15.0
AK231	N, NA, stage:NA, dead, 240 days	14.6
AK185	N, NA, stage:NA, alive, 330 days	13.8
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0218770003	Tumor	0.8
CPT0224390004	Tumor	0.8
CPT0217710008	Tumor	0.7
CPT0123530003	Tumor	0.6
CPT0093510003	Tumor	0.5
CPT0161730003	Tumor	0.5
CPT0078580003	Tumor	0.5
CPT0168080003	Tumor	0.4
CPT0218330004	Tumor	0.4
CPT0217100003	Tumor	0.4
CPT0228220003	Tumor	0.4
CPT0189570004	Tumor	0.4
CPT0206780003	Tumor	0.4
CPT0218830004	Tumor	0.4
CPT0206560003	Tumor	0.4
CPT0087680003	Tumor	0.4
CPT0093450003	Tumor	0.3
CPT0217190003	Tumor	0.3
CPT0224600003	Tumor	0.3
CPT0205780003	Tumor	0.3
CPT0079790003	Tumor	0.3
CPT0168830003	Tumor	0.3
CPT0218890004	Tumor	0.3
CPT0205450004	Tumor	0.3
CPT0225760003	Tumor	0.3
CPT0218690004	Tumor	0.3
CPT0217880003	Tumor	0.3
CPT0207090003	Tumor	0.3
CPT0218960004	Tumor	0.3
CPT0167530003	Tumor	0.3
CPT0167970003	Tumor	0.3
CPT0127420003	Tumor	0.3
CPT0171580008	Tumor	0.2
CPT0002410011	Tumor	0.2
CPT0217430008	Tumor	0.2
CPT0217060003	Tumor	0.2
CPT0167860004	Tumor	0.2
CPT0064650003	Tumor	0.2
CPT0093360003	Tumor	0.2
CPT0125220003	Tumor	0.2
CPT0189850004	Tumor	0.2
CPT0087950003	Tumor	0.2
CPT0089150003	Tumor	0.2
CPT0167640003	Tumor	0.2
CPT0225730003	Tumor	0.2
CPT0064890003	Tumor	0.2
CPT0201710003	Tumor	0.2
CPT0175060003	Tumor	0.2
CPT0167750004	Tumor	0.2
CPT0224540004	Tumor	0.2
CPT0182500003	Tumor	0.1
CPT0206000004	Tumor	0.1
CPT0093590003	Tumor	0.1
CPT0206670004	Tumor	0.1
CPT0182550003	Tumor	0.1
CPT0168720003	Tumor	0.1
CPT0204340003	Normal	0.1
CPT0189460003	Tumor	0.1
CPT0162140003	Tumor	0.1
CPT0205670004	Tumor	0.1
CPT0189750004	Tumor	0.1
CPT0206330003	Tumor	0.1
CPT0125570003	Tumor	0.1
CPT0221180003	Tumor	0.1
CPT0104330003	Tumor	0.1
CPT0168270003	Tumor	0.1
CPT0168480003	Tumor	0.1
CPT0127480003	Tumor	0.1
CPT0168380003	Tumor	0.1
CPT0218670003	Tumor	0.0
CPT0190360004	Tumor	0.0
CPT0093550003	Tumor	0.0
CPT0189250003	Tumor	0.0
CPT0182580003	Tumor	0.0
CPT0208980003	Tumor	0.0
CPT0071100003	Tumor	0.0
CPT0206110003	Tumor	0.0
CPT0190240004	Tumor	0.0
CPT0204390003	Normal	0.0
CPT0199770003	Tumor	0.0
CPT0168590003	Tumor	0.0
CPT0206450003	Tumor	0.0
CPT0189650004	Tumor	-0.1
CPT0204400003	Normal	-0.1
CPT0206230003	Tumor	-0.1
CPT0204330003	Normal	-0.1
CPT0219080004	Tumor	-0.1
CPT0216920008	Tumor	-0.1
CPT0209440003	Tumor	-0.1
CPT0207030003	Tumor	-0.1
CPT0162100003	Tumor	-0.1
CPT0125510003	Tumor	-0.1
CPT0092440003	Tumor	-0.1
CPT0204360003	Normal	-0.1
CPT0205890003	Tumor	-0.1
CPT0206880003	Tumor	-0.1
CPT0087570003	Tumor	-0.1
CPT0087730003	Tumor	-0.2
CPT0162020003	Tumor	-0.2
CPT0224330003	Tumor	-0.2
CPT0205570003	Tumor	-0.2
CPT0204380003	Normal	-0.3
CPT0196850003	Tumor	-0.3
CPT0204410003	Normal	-0.3
CPT0186100003	Tumor	-0.3
CPT0204420003	Normal	-0.3
CPT0204350003	Normal	-0.3
CPT0204370003	Normal	-0.3
CPT0217000004	Tumor	-0.4
CPT0104220003	Tumor	-0.4
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis